{
    "Trade/Device Name(s)": [
        "ACON +/- Midstream Pregnancy Test"
    ],
    "Submitter Information": "ACON Laboratories Inc.",
    "510(k) Number": "K050546",
    "Predicate Device Reference 510(k) Number(s)": [
        "K983090"
    ],
    "Regulatory Class": "Class II",
    "Product Code(s)": [
        "LCX"
    ],
    "Summary Letter Date": "May 2, 2005",
    "Summary Letter Received Date": "May 3, 2005",
    "Submission Date": "",
    "Regulation Number(s)": [
        "21CFR862.1155"
    ],
    "Regulation Name(s)": [
        "Human chorionic gonadotropin (HCG) test system"
    ],
    "Analyte Class(es)": [
        "chemistry"
    ],
    "Analyte(s)": [
        "Human Chorionic Gonadotropin (hCG)"
    ],
    "Specimen Type(s)": [
        "Urine"
    ],
    "Specimen Container(s)": [
        "Midstream urine collection device"
    ],
    "Instrument(s)/Platform(s)": [],
    "Method(s)/Technology(ies)": [
        "Lateral flow immunoassay"
    ],
    "Methodologies": [
        "Antibody-antigen-antibody color particle sandwich binding"
    ],
    "Submission Type(s)": [
        "Test",
        "Specimen collection device"
    ],
    "Document Summary": "FDA 510(k) summary for ACON +/- Midstream Pregnancy Test, a lateral flow immunoassay for qualitative detection of hCG in urine",
    "Indications for Use Summary": "Intended for over-the-counter use for qualitative detection of elevated hCG in urine to aid in determination of pregnancy",
    "fda_folder": "Clinical Chemistry"
}